 Shares of Immunome Inc. blasted 212.6 higher toward new highs Thursday, to pace all of the premarket gainers trading on major U.S. exchanges, after biopharmaceutical company said it has isolated potent antibodies that are capable of neutralizing several SARS-CoV-2 variants, including the South African Variant B.1.351 in pseudovirus testing. Trading volume was about 506,600 shares, compared with the full-day average of about 117,600 shares. 